Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD

4 Views
administrator
administrator
07/30/23

Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next